Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Ernesto Vigna"'
Autor:
Uros Markovic, Ernesto Vigna, Francesco Grimaldi, Giulia Palazzo, Antonio M. Risitano, Massimo Martino, Maria Cristina Pirosa, Giuseppe Milone, Stefania Stella, Giovanni Pisapia, Angelo Curto Pelle, Raffaele Palmieri, Luca Scalise, Francesco Di Raimondo, Stefania Tringali, Salvatore Leotta, Giulio Antonio Milone, Valerio Leotta, Fausto Palmieri, Paola Carluccio, Mary Ann Di Giorgio, Giorgina Specchia, Anna Bulla, Mario Annunziata
Publikováno v:
Annals of Hematology. 100:1743-1753
The experience of third-generation tyrosine kinase inhibitor ponatinib treatment in Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph'+ ALL) patients post-allogeneic transplantation is limited. We retrospectively collected data on 25
Autor:
Mercedes Gori, Ernesto Vigna, Antonella Pontari, Anna Grazia Recchia, Giovanni Tripepi, Massimo Martino, Antonia Dattola, Tiziana Moscato, Santina Barilla, Annalisa Pitino, Massimo Gentile, Fortunato Morabito
Publikováno v:
Biology of Blood and Marrow Transplantation. 23:1215-1220
A longitudinal, prospective, observational, single-center, cohort study on healthy donors (HDs) was designed to identify predictors of CD34+ cells on day 5 with emphasis on the predictive value of the basal CD34+ cell count. As potential predictors o
Autor:
Lucio Morabito, Francesco Mendicino, Anna Grazia Recchia, Fortunato Morabito, Giovanna Giagnuolo, Massimo Gentile, Ernesto Vigna
Publikováno v:
European Journal of Haematology. 95:377-388
The advent of high-dose melphalan with autologous stem-cell transplantation (ASCT), the availability of novel agents such as thalidomide, lenalidomide (immunomodulatory drugs or IMiDs) and bortezomib (proteasome inhibitor) and improvements in support
Autor:
Massimo Martino, Anna Grazia Recchia, Fortunato Morabito, Ernesto Vigna, Lucio Morabito, Massimo Gentile
Publikováno v:
Expert Opinion on Pharmacotherapy. 15:1315-1320
Since in multiple myeloma (MM) patients the depth of response achieved with autologous stem-cell transplantation (ASCT) seems to correlate with the time to progression, various strategies have been undertaken to control disease and improve prognosis.
Autor:
Laura De Stefano, Fortunato Morabito, Eugenio Lucia, Massimo Martino, Massimo Gentile, Ernesto Vigna, Anna Grazia Recchia, Carla Mazzone, Sabrina Bossio, Lucio Morabito, Teresa Granata, Angela Palummo
Publikováno v:
Expert Opinion on Pharmacotherapy. 14:2263-2280
Bendamustine is a unique bifunctional alkylating agent with promising activity in multiple myeloma (MM). It is currently licensed in Europe for use as frontline treatment with prednisolone for patients with MM who are unsuitable for transplantation a
Autor:
Massimo Martino, Giuseppe Messina, Giuseppe Irrera, Giuseppe Console, Roberta Fedele, Mauro Montanari, Massimo Offidani, Fortunato Morabito, Ernesto Vigna, Massimo Gentile, Attilio Olivieri, Tiziana Moscato
Publikováno v:
Expert Opinion on Investigational Drugs. 22:619-634
The role of high-dose chemotherapy (HDC) followed by autologous-progenitor cell transplantation (auto-HPCT) in the treatment of multiple myeloma (MM) continues to evolve in the novel agent era. Administration of high-dose melphalan (HDM) is considere
Autor:
Fortunato Morabito, Ernesto Vigna, Rosellina Morelli, Carla Mazzone, A. De Vivo, Eugenio Lucia, Massimo Gentile, Anna Grazia Recchia, Nicola Vianelli
Publikováno v:
Transplant Infectious Disease. 12:428-431
E. Vigna, A. De Vivo, M. Gentile, R. Morelli, E. Lucia, C. Mazzone, A.G. Recchia, N. Vianelli, F. Morabito. Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompromised patients. Transpl Infect Dis 2010: 12: 428–431. All
Autor:
Ernesto Vigna, Fortunato Morabito, Lucio Morabito, Massimo Gentile, Maria Cuzzola, Massimo Martino, Anna Grazia Recchia
Publikováno v:
Immunotherapy. 5(6)
553 ISSN 1750-743X 10.2217/IMT.13.30 © 2013 Future Medicine Ltd Immunotherapy (2013) 5(6), 553–556 “The transferability of the acute graft-versus-host disease-linked gene-expression profiles might suggest a major epigenetic influence ... a novel
Autor:
Ernesto Vigna, Michele Malagola, Giovanni Martinelli, Michele Bianchini, Stavroula Gaitani, Giuseppe Visani, Michele Baccarani, Pier Paolo Piccaluga, Costanza Bosi, Michela Rondoni
Publikováno v:
Leukemia & Lymphoma. 45:731-733
Despite aggressive approaches, including second transplant, donor lymphocyte infusion and several new agents, the prognosis of acute lymphoid leukemia (ALL) patients relapsing after stem-cell transplantation (SCT) remains poor. Monoclonal-antibodies
Autor:
Giuseppe Avvisati, Giuliana Leopardi, Luca De Rosa, Michele Baccarani, Silvana Capalbo, Silvestro Volpe, Immacolata Attolico, Silvana Pasini, Alessandro Gozzetti, Antonio Capaldi, Giulia Perrone, Elena Zamagni, Giuseppe Mele, Patrizia Pregno, Alessandro Moscetti, Anna Mele, Vittorio Fregoni, Fausto Rossini, Ernesto Vigna, Michele Magni, Giuseppe Nunziata, Monica Crugnola, Luigi Podda, Sergio Amadori, Anna Marina Liberati, Michele Cavo, Annamaria Brioli, Giuliana Farina
Publikováno v:
ResearcherID
Abstract 317 Introduction: The novel agents bortezomib, thalidomide and lenalidomide have been successfully incorporated into autologous stem-cell transplantation (ASCT) as up-front therapy for newly diagnosed MM. However, several reports have raised